Strategic Investment Solutions Inc. IL Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Strategic Investment Solutions Inc. IL purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,773 shares of the pharmacy operator’s stock, valued at approximately $34,000.

Other large investors also recently added to or reduced their stakes in the company. Capital World Investors boosted its stake in Walgreens Boots Alliance by 57.5% during the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after acquiring an additional 10,612,373 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its position in shares of Walgreens Boots Alliance by 98.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after purchasing an additional 2,992,648 shares in the last quarter. Newport Trust Company LLC acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $31,028,000. Swedbank AB bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at $16,365,000. Finally, Minneapolis Portfolio Management Group LLC acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth $13,710,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on WBA shares. Bank of America lowered their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Royal Bank of Canada lowered their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. TD Cowen dropped their target price on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. Barclays reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Finally, UBS Group dropped their price objective on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Stock Down 0.3 %

WBA stock opened at $8.67 on Friday. The company has a market cap of $7.48 billion, a price-to-earnings ratio of -1.29, a P/E/G ratio of 1.03 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The business has a 50 day moving average price of $9.79 and a two-hundred day moving average price of $13.99. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were issued a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 11.53%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.